{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:01:33Z","timestamp":1768899693270,"version":"3.49.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"abstract":"<jats:p>\n                    This study aims to assess the clinical efficacy of triamcinolone acetonide (TAC) injections combined with hyaluronic acid (HA) for treating periorbital depressed scars. Clinical data of periorbital scarring in 16 patients (26 cases of scarring in total) who attended the Second Hospital of Dalian Medical University between January 2018 and January 2020 were retrospectively analyzed. Scars were scored using the Vancouver Scar Scale (VSS) before and after treatment, and scar softness scores and scar indentations were recorded. TAC was injected into the scar every 2 weeks, and the softness of the scar was evaluated before each TAC treatment. When the softness score of the VSS dropped to 1 or below, HA was filled in the subcutaneous layer of the scar. The treatment was followed up for 12 months, and digital photographs were taken of the treatment process as a basis for evaluating the treatment effect. The occurrence of adverse injection reactions was also recorded. SPSS27.0 was used for statistical analysis, and\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.05 was considered statistically significant. The softness scores in VSS of 26 cases of scarring were compared before TAC treatment with 1 month after HA treatment, and the difference was statistically significant (\n                    <jats:italic toggle=\"yes\">t<\/jats:italic>\n                    \u2005=\u200518.44,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.01). The VSS scores before TAC treatment were compared with 1 month after HA treatment and the difference was statistically significant (\n                    <jats:italic toggle=\"yes\">t<\/jats:italic>\n                    \u2005=\u200517.3,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.01). The difference was statistically significant when comparing the VSS scores at 6 months versus 12 months after HA treatment (\n                    <jats:italic toggle=\"yes\">t<\/jats:italic>\n                    \u2005=\u20052.74,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.05). During TAC treatment, localized erythema appeared on the scar in 5 cases and skin thinning on the scar surface in 3 patients, which were corrected after 1 year of follow-up after HA treatment. At the time of HA injection, none of the 26 cases had allergic symptoms or vascular embolism. At 1-year follow-up, only 2 cases had reappearance of indentation of the scar (both &lt;1\u2009mm). Triamcinolone Acetonide injections combined with HA is safe and feasible for the treatment of periorbital scarring and can effectively improve the appearance of patients with periorbital scarring.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047124","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:01:53Z","timestamp":1768849313000},"page":"e47124","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Hyaluronic acid injection aided by triamcinolone acetonide for treating periorbital depressed scars: A retrospective study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7774-1986","authenticated-orcid":false,"given":"Yu","family":"Xue","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, The Second Hospital of Dalian Medical University, Dalian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlei","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second Hospital of Dalian Medical University, Dalian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second Hospital of Dalian Medical University, Dalian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second Hospital of Dalian Medical University, Dalian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don O.","family":"Kikkawa","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Diego, La Jolla, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second Hospital of Dalian Medical University, Dalian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260119","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jamafacial.2014.1131","article-title":"The social penalty of facial lesions: new evidence supporting high-quality reconstruction.","volume":"17","author":"Dey","year":"2015","journal-title":"JAMA Facial Plast Surg"},{"key":"R2-20260119","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jamafacial.2015.2365","article-title":"The cost of facial deformity: a health utility and valuation study.","volume":"18","author":"Dey","year":"2016","journal-title":"JAMA Facial Plast Surg"},{"key":"R3-20260119","first-page":"1","article-title":"The safety and efficacy of intralesional verapamil versus intralesional triamcinolone acetonide for keloids and hypertrophic scars: a systematic review and meta-analysis.","volume":"33","author":"Jiang","year":"2020","journal-title":"Adv Skin Wound Care"},{"key":"R4-20260119","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.burns.2018.05.005","article-title":"Comparison of intralesional verapamil versus intralesional corticosteroids in treatment of keloids and hypertrophic scars: a randomized controlled trial.","volume":"44","author":"Abedini","year":"2018","journal-title":"Burns"},{"key":"R5-20260119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0925-5710(98)00038-3","article-title":"Mechanisms involved in chemotherapy-induced apoptosis and their implications in cancer chemotherapy.","volume":"68","author":"Kamesaki","year":"1998","journal-title":"Int J Hematol"},{"key":"R6-20260119","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1055\/s-0038-1669400","article-title":"Facial scar improvement procedures.","volume":"34","author":"Newberry","year":"2018","journal-title":"Facial Plast Surg"},{"key":"R7-20260119","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.mehy.2015.01.023","article-title":"Midfacial rejuvenation by hyaluronic acid fillers and subcutaneous adipose tissue \u2013 a new concept.","volume":"84","author":"Wollina","year":"2015","journal-title":"Med Hypotheses"},{"issue":"3 Pt 1","key":"R8-20260119","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaad.2004.09.018","article-title":"Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study.","volume":"52","author":"Kontochristopoulos","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R9-20260119","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1473-2165.2010.00508.x","article-title":"Hyaluronic acid filler for steroid atrophy.","volume":"9","author":"Elliott","year":"2010","journal-title":"J Cosmet Dermatol"},{"key":"R10-20260119","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00004630-199509000-00013","article-title":"The Vancouver scar scale: an administration tool and its interrater reliability.","volume":"16","author":"Baryza","year":"1995","journal-title":"J Burn Care Rehabil"},{"key":"R11-20260119","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bjps.2014.04.011","article-title":"Updated scar management practical guidelines: non-invasive and invasive measures.","volume":"67","author":"Monstrey","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R12-20260119","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1097\/PRS.0b013e3182a8070c","article-title":"Update on scar management: guidelines for treating Asian patients.","volume":"132","author":"Kim","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"R13-20260119","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bjps.2012.09.012","article-title":"Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study.","volume":"66","author":"Ziade","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"4S Suppl 1","key":"R14-20260119","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/SAP.0000000000002090","article-title":"Triamcinolone acetonide suppresses keloid formation through enhancing apoptosis in a nude mouse model.","volume":"83","author":"Chen","year":"2019","journal-title":"Ann Plast Surg"},{"key":"R15-20260119","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-0036-1584824","article-title":"Update on postsurgical scar management.","volume":"30","author":"Commander","year":"2016","journal-title":"Semin Plast Surg"},{"key":"R16-20260119","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/SCS.0000000000001358","article-title":"Late-onset adverse reactions related to hyaluronic acid dermal filler for aesthetic soft tissue augmentation.","volume":"26","author":"Curi","year":"2015","journal-title":"J Craniofac Surg"},{"key":"R17-20260119","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10529-006-9219-z","article-title":"Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications.","volume":"29","author":"Kogan","year":"2007","journal-title":"Biotechnol Lett"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:01:55Z","timestamp":1768849315000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047124","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"2024-06-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}